IP Library Granted Patent US 7,381,220
Granted Patent B2
US 7,381,220 · App. 10/676,815 · Granted Jun 3, 2008

Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,381,220
App. No.
10/676,815
Granted
Jun 3, 2008
Kind
B2
Abstract

Devices, systems and methods supplement, repair, or replace a native heart valve. The devices, systems, and methods employ an implant that, in use, extends adjacent a valve annulus. The implant includes a mobile neoleaflet element that occupies the space of at least a portion of one native valve leaflet. The implant mimics the one-way valve function of a native leaflet, to resist or prevent retrograde flow. The implant restores normal coaptation of the leaflets to resist retrograde flow, thereby resisting eversion and/or prolapse, which, in turn, reduces regurgitation.

Claims (13)

1. A method for supplementing, repairing, or replacing a native heart valve leaflet or leaflets comprising

selecting a native heart valve having an annulus, native heart valve leaflets, and generally opposite leaflet commissures spaced apart by a maximum cross-annulus distance defining a major axis of the annulus,

providing an implant comprising an elastic scaffold, at least a portion of the elastic scaffold defining a pseudo-annulus, the elastic scaffold comprising a normal, unloaded condition including a spring constant to undergo compression in response to applied external compression forces into an elastically loaded condition, the implant further comprising at least two struts coupled to the elastic scaffold in generally oppositely spaced apart positions defining, when the elastic scaffold is in the normal, unloaded condition, a normal cross-strut distance that is greater than the maximum cross-annulus distance, the implant further comprising a neoleaflet element coupled to the elastic scaffold within pseudo-annulus and being sized and shaped to occupy the space of at least a portion of one native heart valve leaflet to provide a one-way valve function that, in response to a first pressure condition, assumes a valve opened condition within the pseudo-annulus and, in response to a second pressure condition, assumes a valve closed condition within the pseudo-annulus,

introducing the implant into a heart with the elastic scaffold in the normal, unloaded condition,

applying external compression forces at the at least two struts to reduce the normal cross-strut distance to place the elastic scaffold into the elastically loaded condition,

while the elastic scaffold is in the elastically loaded condition, placing the struts into engagement with tissue at or near the leaflet commissures to apply tension and outwardly displace and separate tissue along the major axis of the annulus to reshape the annulus for leaflet coaptation, and

while the struts are placed in engagement with tissue at or near the leaftlet commissures, providing a one-way valve function with the neoleaflet element that, in response to a first pressure condition, assumes the valve opened condition and, in response to second pressure condition, assumes the valve closed condition, the at least two struts engaging tissue at or near the leaflet commissures to brace the elastic scaffold while in the elastically loaded condition against migration within the annulus during the one-way valve function.

2. A method according to claim 1

wherein the introducing comprises using an open heart surgical procedure.

3. A method according to claim 1

wherein the introducing comprises using a surgical procedure in which the implant is carried within a catheter.

4. A method according to claim 1

wherein the introducing comprises using an intravascular surgical procedure.

Assignments (9)
CORRECTIVE ASSIGNMENT TO CORRECT THE SIGNATURES ON THE ORIGINALLY DOCUMENT PREVIOUSLY RECORDED AT REEL: 020814 FRAME: 0208. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT/SECURITY AGREEMENT. Recorded Mar 2, 2016
From: AMPLE MEDICAL, INC.
To: VENTURE LENDING & LEASING IV, INC.; VENTURE LENDING & LEASING V, INC.
Reel/Frame 037974/0732 →
CORRECTIVE ASSIGNMENT TO CORRECT THE OMISSION OF PAGE 3 IN THE ORIGINAL FILED DOCUMENT PREVIOUSLY RECORDED AT REEL: 016127 FRAME: 0400. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Mar 2, 2016
From: AMPLE MEDICAL, INC.
To: VENTURE LENDING & LEASING IV, INC.
Reel/Frame 037974/0803 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE CONVEYING PARTIES PREVIOUSLY RECORDED ON REEL 023928 FRAME 0968. ASSIGNOR(S) HEREBY CONFIRMS THE BILL OF SALE. Recorded Feb 5, 2016
From: VENTURE LENDING & LEASING IV, INC.; VENTURE LENDING & LEASING V, INC.
To: MVRX, INC.
Reel/Frame 037704/0486 →
BILL OF SALE Recorded Feb 15, 2010
From: AMPLE MEDICAL, INC.
To: MVRX, INC.
Reel/Frame 023928/0968 →
BILL OF SALE Recorded Jan 29, 2010
From: VENTURE LENDING & LEASING IV, INC.; VENTURE LENDING & LEASING V, INC.
To: MVRX, INC.
Reel/Frame 023882/0030 →
PATENT TRANSFER STATEMENT (UNDER UNIFORM COMMERCIAL CODE SECTION 9-619) Recorded Dec 18, 2009
From: AMPLE MEDICAL, INC.
To: VENTURE LENDING & LEASING IV, INC.; VENTURE LENDING & LEASING V, INC.
Reel/Frame 023699/0672 →
SECURITY INTEREST Recorded Apr 11, 2008
From: AMPLE MEDICAL, INC.
To: VENTURE LENDING & LEASING IV, INC. AND VENTURE LENDING & LEASING V, INC.
Reel/Frame 020814/0208 →
SECURITY INTEREST Recorded Jan 7, 2005
From: AMPLE MEDICAL, INC.
To: VENTURE LENDING & LEASING IV, INC.
Reel/Frame 016127/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2003
From: RAHDERT, DAVID A.; MACOVIAK, JOHN A.; MACHOLD, TIMOTHY R.; CHANG, ROBERT T.; SOSS, RICK A.
To: AMPLE MEDICAL, INC.
Reel/Frame 014759/0215 →